| Application no. and date | 23730718.6 (espacenet) (Federated) (European Patent Register), 20230518 | | Patent/reg. no. and date | DK/EP 4429693, 20250226 | | Publication date | 20240918 | | Priority no. and date | GB 202207263, 20220518 | | EP pub. no. and date |
EP 4429693 20240918 | | Effective date | | | Applicant/owner | Annexin Pharmaceuticals AB, Kammakargatan 48
111 60 Stockholm, SE | | Applicant ref. no. | ANNQ/P85607EP | | Inventor | HAEGERSTRAND, Anders,
11160 Stockholm, SE,
FROSTEGÿRD, Anna,
11160 Stockholm, SE | | Representative | Potter Clarkson A/S, Regnbuepladsen 7, 4. tv., 1550 København V, DK | | Opponent | | | IPC Class | A61K 38/17 (2006.01) , A61P 27/02 (2006.01) | | Title | MONOMERIC ANNEXIN A5 FOR USE IN THE TREATMENT OF MACULAR OEDEMA OR RETINAL VEIN OCCLUSION | | Int. application no. | EP2023063441 | | Int. publication no. | WO2023227468 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
